BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$478M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Alibaba
BABA
|
+$295M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$261M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$995M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$128M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$112M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$109M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.51% |
| 2 | Financials | 5.78% |
| 3 | Consumer Discretionary | 5.73% |
| 4 | Healthcare | 5.19% |
| 5 | Communication Services | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
International Seaways
INSW
$4.58B
| $95.9K | ﹤0.01% |
5,048
-10
| -0.2% | -$185 |
|
2927
Quad
QUAD
$507M
| $95.7K | ﹤0.01% |
12,095
+664
| +6% | +$6.95K |
|
|
STL
2928
DELISTED
Sterling Bancorp
STL
| $95.5K | ﹤0.01% |
4,490
+4,106
| +1,069% | +$84.3K |
|
2929
ATN International
ATNI
$478M
| $95.5K | ﹤0.01% |
1,654
-773
| -32% | -$46.3K |
|
2930
Phibro Animal Health
PAHC
$1.37B
| $95.5K | ﹤0.01% |
3,005
-1,708
| -36% | -$53.6K |
|
|
CGC
2931
Canopy Growth
CGC
$426M
| $95.3K | ﹤0.01% |
237
+203
| +597% | +$89.3K |
|
|
NVEE
2932
DELISTED
NV5 Global
NVEE
| $95.2K | ﹤0.01% |
4,676
-3,184
| -41% | -$56.8K |
|
|
INXN
2933
DELISTED
Interxion Holding N.V.
INXN
| $94.8K | ﹤0.01% |
1,246
-1,091
| -47% | -$77.9K |
|
2934
Theravance Biopharma
TBPH
$878M
| $94.6K | ﹤0.01% |
5,791
-4,174
| -42% | -$84.6K |
|
|
RTL
2935
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $94.4K | ﹤0.01% |
8,659
+4,695
| +118% | +$49K |
|
|
CCF
2936
DELISTED
Chase Corporation
CCF
| $94.2K | ﹤0.01% |
875
-638
| -42% | -$63.2K |
|
|
DRNA
2937
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $94.1K | ﹤0.01% |
5,973
-5,204
| -47% | -$70.8K |
|
|
EVRI
2938
DELISTED
Everi Holdings
EVRI
| $94K | ﹤0.01% |
7,881
-5,994
| -43% | -$65.1K |
|
2939
CALL
TSMC
TSM
$2.23T
| $94K | ﹤0.01% |
24
| – | – |
|
|
2940
PUT
TSMC
TSM
$2.23T
| $94K | ﹤0.01% |
24
| – | – |
|
2941
DigitalBridge
DBRG
$2.95B
| $93.9K | ﹤0.01% |
4,697
-25,983
| -85% | -$539K |
|
2942
M/I Homes
MHO
$3.82B
| $93.3K | ﹤0.01% |
3,270
-2,511
| -43% | -$70.8K |
|
|
SRCL
2943
DELISTED
Stericycle Inc
SRCL
| $93.3K | ﹤0.01% |
1,954
-278
| -12% | -$14.1K |
|
|
ALDR
2944
DELISTED
Alder Biopharmaceuticals
ALDR
| $93.3K | ﹤0.01% |
7,926
-5,615
| -41% | -$68K |
|
2945
John B. Sanfilippo & Son
JBSS
$989M
| $93.1K | ﹤0.01% |
1,168
-629
| -35% | -$47.8K |
|
2946
Bank of Marin Bancorp
BMRC
$462M
| $93K | ﹤0.01% |
2,267
-582
| -20% | -$24.4K |
|
2947
Travere Therapeutics
TVTX
$5.86B
| $92.6K | ﹤0.01% |
4,610
-3,979
| -46% | -$78.6K |
|
|
SPTN
2948
DELISTED
SpartanNash
SPTN
| $92.6K | ﹤0.01% |
7,934
+394
| +5% | +$5.62K |
|
2949
Allogene Therapeutics
ALLO
$683M
| $92.4K | ﹤0.01% |
+3,441
| New | +$95.9K |
|
2950
Myers Industries
MYE
$1.23B
| $92.2K | ﹤0.01% |
4,783
-2,541
| -35% | -$45.7K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2019 Portfolio in Review
As of Q2 2019, BNP Paribas Financial Markets held 4,663 positions worth $50.2B, up 8.5% from $46.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets's Q2 2019 filing shows 353 new, 1,075 increased, 2,687 reduced and 125 closed positions. Its largest new stake was Cigna: 315,599 shares worth $49.7M. The largest sale was Invesco QQQ Trust, an estimated $995M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.6% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2019 buy was Cigna: 315,599 shares worth $49.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $478M increase.
- BNP Paribas Financial Markets's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $995M.
- BNP Paribas Financial Markets fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $40.4M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $50.2B portfolio in Q2 2019.
- BNP Paribas Financial Markets opened 353 new positions and closed 125 in Q2 2019.
- BNP Paribas Financial Markets's portfolio value rose 8.5% quarter-over-quarter to $50.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2019, filed 30 Jul 2019.